These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21943224)

  • 1. Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya.
    Lawford H; Zurovac D; O'Reilly L; Hoibak S; Cowley A; Munga S; Vulule J; Juma E; Snow RW; Allan R
    Malar J; 2011 Sep; 10():281. PubMed ID: 21943224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, Ethiopia.
    Lemma H; Löfgren C; San Sebastian M
    Malar J; 2011 Dec; 10():349. PubMed ID: 22141751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting.
    Gore-Langton GR; Alenwi N; Mungai J; Erupe NI; Eves K; Kimwana FN; Soti D; Akhwale W; Hassan FA; Juma E; Allan R
    Malar J; 2015 Mar; 14():125. PubMed ID: 25888895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provider knowledge of treatment policy and dosing regimen with artemether-lumefantrine and quinine in malaria-endemic areas of western Kenya.
    Watsierah CA; Onyango RO; Ombaka JH; Abong'o BO; Ouma C
    Malar J; 2012 Dec; 11():436. PubMed ID: 23273046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to treatment with artemether-lumefantrine for uncomplicated malaria in rural Malawi.
    Mace KE; Mwandama D; Jafali J; Luka M; Filler SJ; Sande J; Ali D; Kachur SP; Mathanga DP; Skarbinski J
    Clin Infect Dis; 2011 Oct; 53(8):772-9. PubMed ID: 21921220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of text-message reminders on paediatric malaria treatment adherence and their post-treatment return to health facilities in Kenya: a randomized controlled trial.
    Talisuna AO; Oburu A; Githinji S; Malinga J; Amboko B; Bejon P; Jones C; Snow RW; Zurovac D
    Malar J; 2017 Jan; 16(1):46. PubMed ID: 28122622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya.
    Zurovac D; Njogu J; Akhwale W; Hamer DH; Snow RW
    Trop Med Int Health; 2008 Jan; 13(1):99-107. PubMed ID: 18291008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.
    Wasunna B; Zurovac D; Goodman CA; Snow RW
    Malar J; 2008 Feb; 7():29. PubMed ID: 18252000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correct dosing of artemether-lumefantrine for management of uncomplicated malaria in rural Tanzania: do facility and patient characteristics matter?
    Masanja IM; Selemani M; Khatib RA; Amuri B; Kuepfer I; Kajungu D; de Savigny D; Kachur SP; Skarbinski J
    Malar J; 2013 Dec; 12():446. PubMed ID: 24325267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania.
    Kabanywanyi AM; Lengeler C; Kasim P; King'eng'ena S; Schlienger R; Mulure N; Genton B
    Malar J; 2010 Feb; 9():48. PubMed ID: 20149235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in health workers' malaria diagnosis and treatment practices in Kenya.
    Juma E; Zurovac D
    Malar J; 2011 Jan; 10():1. PubMed ID: 21214892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescriber practices and patient adherence to artemisinin-based combination therapy for the treatment of uncomplicated malaria in Guinea, 2016.
    Camara A; Moriarty LF; Guilavogui T; Diakité PS; Zoumanigui JS; Sidibé S; Bah I; Kaba I; Kourouma D; Zoumanigui K; Plucinski M
    Malar J; 2019 Jan; 18(1):23. PubMed ID: 30683128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenya.
    Onyango EO; Ayodo G; Watsierah CA; Were T; Okumu W; Anyona SB; Raballah E; Okoth JM; Gumo S; Orinda GO; Ouma C
    BMC Infect Dis; 2012 Jun; 12():143. PubMed ID: 22726955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos.
    Mayxay M; Khanthavong M; Chanthongthip O; Imwong M; Pongvongsa T; Hongvanthong B; Phompida S; Vanisaveth V; White NJ; Newton PN
    Malar J; 2012 Jun; 11():184. PubMed ID: 22681769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do patients adhere to over-the-counter artemisinin combination therapy for malaria? evidence from an intervention study in Uganda.
    Cohen JL; Yavuz E; Morris A; Arkedis J; Sabot O
    Malar J; 2012 Mar; 11():83. PubMed ID: 22443291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda.
    Fogg C; Bajunirwe F; Piola P; Biraro S; Checchi F; Kiguli J; Namiiro P; Musabe J; Kyomugisha A; Guthmann JP
    Am J Trop Med Hyg; 2004 Nov; 71(5):525-30. PubMed ID: 15569777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya.
    Juma EA; Obonyo CO; Akhwale WS; Ogutu BR
    Malar J; 2008 Dec; 7():262. PubMed ID: 19102746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi.
    Bell DJ; Wootton D; Mukaka M; Montgomery J; Kayange N; Chimpeni P; Hughes DA; Molyneux ME; Ward SA; Winstanley PA; Lalloo DG
    Malar J; 2009 Aug; 8():204. PubMed ID: 19709418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children.
    Abdulla S; Sagara I
    Malar J; 2009 Oct; 8 Suppl 1(Suppl 1):S7. PubMed ID: 19818174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India.
    Valecha N; Srivastava P; Mohanty SS; Mittra P; Sharma SK; Tyagi PK; Pradhan K; Dev V; Singh R; Dash AP; Sharma YD
    Malar J; 2009 May; 8():107. PubMed ID: 19454000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.